Envestnet Asset Management »

Travere Therapeutics shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.9M 50k 38.21
2023-06-30 $164k 11k 15.36
2023-03-31 $224k 10k 22.49
2022-09-30 $247k 10k 24.64
2022-06-30 $240k 9.9k 24.27
2022-03-31 $267k 10k 25.77
2021-12-31 $284k 9.1k 31.08
2021-09-30 $217k 9.0k 24.20